HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1 - Full Text View

Purpose

The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.

Condition	Intervention	Phase
Behavior Therapy	Behavioral: Behavior Therapy	Phase 3


Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

AIDS risk behavior


Estimated Enrollment:	630
Study Start Date:	April 2004
Study Completion Date:	September 2005
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00084175

Locations


United States, California
Matrix Institute on Addictions
Rancho Cucamonga, California, United States, 91730
San Francisco General Hospital
San Francisco, California, United States, 94110
United States, Connecticut
Hartford Dispensary
New Britain, Connecticut, United States, 06051
CT Renaissance, Inc.
Norwalk, Connecticut, United States, 06852
United States, New Mexico
Life Link
Santa Fe, New Mexico, United States, 87505
United States, New York
Staten Island University Hospital
Staten Island, New York, United States, 10309
United States, North Carolina
Addiction Drug Services-Highpoint
High Point, North Carolina, United States, 27265
South Light
Raleigh, North Carolina, United States, 27604
United States, Ohio
Comprehensive Addiction Services System
Toledo, Ohio, United States, 43620
United States, Pennsylvania
The Consortium
Philadelphia, Pennsylvania, United States, 19104
Thomas Jefferson Intensive Sub. Abuse TP
Philadelphia, Pennsylvania, United States, 19107
United States, South Carolina
LRADAC-Lexington-Richmond Alcohol & Drug Council
Columbia, South Carolina, United States, 29204
United States, Washington
Evergreen Treatment Services
Seattle, Washington, United States, 98134 1618
United States, West Virginia
Prestera Center for Mental Health Svcs.
Huntington, West Virginia, United States, 25704

Sponsors and Collaborators

University of Washington

Investigators


Principal Investigator:	Donald Calsyn, Ph.D.	University of Washington

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Calsyn DA, Campbell AN, Tross S, Hatch-Maillette MA. Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations. Am J Drug Alcohol Abuse. 2011 Sep;37(5):294-300. doi: 10.3109/00952990.2011.596874.

Calsyn DA, Crits-Christoph P, Hatch-Maillette MA, Doyle SR, Song YS, Coyer S, Pelta S. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction. 2010 Jan;105(1):100-8. doi: 10.1111/j.1360-0443.2009.02812.x.

Calsyn DA, Hatch-Maillette M, Tross S, Doyle SR, Crits-Christoph P, Song YS, Harrer JM, Lalos G, Berns SB. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. J Subst Abuse Treat. 2009 Sep;37(2):138-50. doi: 10.1016/j.jsat.2008.11.008. Epub 2009 Jan 15.


Responsible Party:	Donald Calsyn, Ph.D., University of Washington
ClinicalTrials.gov Identifier:	NCT00084175 History of Changes
Other Study ID Numbers:	NIDA-CTN-0018-1
Study First Received:	June 8, 2004
Last Updated:	April 13, 2010
Health Authority:	United States: Federal Government

ClinicalTrials.gov processed this record on September 28, 2016